Plasmid-mediated quinolone resistance in Salmonella from South Africa.
Govender
Nevashan
N
Enteric Diseases Reference Unit, National Institute for Communicable Diseases, Johannesburg, South Africa.
Smith
Anthony M
AM
University of the Witwatersrand, Johannesburg, South Africa.|Enteric Diseases Reference Unit, National Institute for Communicable Diseases, Johannesburg, South Africa.
Karstaedt
Alan S
AS
Chris Hani Baragwanath Hospital, Johannesburg, South Africa.|University of the Witwatersrand, Johannesburg, South Africa.
Keddy
Karen H
KH
University of the Witwatersrand, Johannesburg, South Africa.|Enteric Diseases Reference Unit, National Institute for Communicable Diseases, Johannesburg, South Africa.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology*; D005798:Genes, Bacterial; D006801:Humans; D009154:Mutation; D011815:R Factors / Q000235:genetics; D012480:Salmonella Infections / Q000188:drug therapy* / Q000382:microbiology*; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D013019:South Africa
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D002939:Ciprofloxacin